Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.20.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Summary of anti-dilutive equivalent units outstanding excluded from earnings per share calculation
The following table summarizes equivalent units outstanding that were excluded from the earnings per share calculation because their effects were anti-dilutive (in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
Common stock purchase warrants
279

 
402

Stock options
73

 
76

Convertible Note

 
126

Advance from NDX

 
90

Restricted shares of common stock

 
1

 
352

 
695